when his patients ask how long they’ll be at the hospital with a procedure like this, he tries to manage their expectations..
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
"we are calling for the immediate implementation of a statutory duty of candour for the health trusts.".
biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".